Key points are not available for this paper at this time.
Quality of life metrics in hypertension require standardization; leaves open their role as primary endpoints in trials.
*From the Department of Clinical Pharmacology, Karolinska Hospital, Stockholm, Behavioural Medicine, Astra Haessle Research Laboratories, Mölndal, and the *Department of Medicine, Östra Hospital, Gothenburg, Sweden. Requests for reprints to: Dr P. Hjemdahl, Department of Clinical Pharmacology, Karolinska Hospital, S-104 01 Stockholm, Sweden. Date of receipt: 28 April 1992; revised: 15 September 1992; accepted: 6 October 1992.
No takes yet. Share an insight, caveat, or question.
Hjemdahl et al. (1992) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: